Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus
    2.
    发明授权
    Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus 有权
    电子照相感光构件,处理盒和电子照相设备

    公开(公告)号:US07364824B2

    公开(公告)日:2008-04-29

    申请号:US11617347

    申请日:2006-12-28

    CPC classification number: G03G5/14786 G03G5/0614 G03G5/071 G03G5/14717

    Abstract: An electrophotographic photosensitive member, a process cartridge and an electrophotographic apparatus are provided which not only secure mechanical strength sufficiently but also bring a vast improvement in charge transport performance and which can well satisfy electrical properties. An electrophotographic photosensitive member is provided an outermost surface layer of which contains at least a charge transporting compound having chain polymerizable functional groups which is represented by the following general formula (1-1) or (1-2); the charge transporting compound having been polymerized or cross-linked and cured. Also provided are a process cartridge and an electrophotographic apparatus which have such a photosensitive member.

    Abstract translation: 提供了一种电子照相感光构件,处理盒和电子照相设备,其不仅充分确保机械强度,而且还可以极大地改善电荷传输性能,并且可以很好地满足电性能。 提供电子照相感光构件,其最外表面层至少包含由以下通式(1-1)或(1-2)表示的具有链可聚合官能团的电荷输送化合物; 电荷输送化合物已经聚合或交联并固化。 还提供了具有这种感光构件的处理盒和电子照相设备。

    ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS
    7.
    发明申请
    ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS 有权
    电子照相感光元件,工艺盒和电子照相设备

    公开(公告)号:US20070111121A1

    公开(公告)日:2007-05-17

    申请号:US11617347

    申请日:2006-12-28

    CPC classification number: G03G5/14786 G03G5/0614 G03G5/071 G03G5/14717

    Abstract: An electrophotographic photosensitive member, a process cartridge and an electrophotographic apparatus are provided which not only secure mechanical strength sufficiently but also bring a vast improvement in charge transport performance and which can well satisfy electrical properties. An electrophotographic photosensitive member is provided an outermost surface layer of which contains at least a charge transporting compound having chain polymerizable functional groups which is represented by the following general formula (1-1) or (1-2); the charge transporting compound having been polymerized or cross-linked and cured. Also provided are a process cartridge and an electrophotographic apparatus which have such a photosensitive member.

    Abstract translation: 提供了一种电子照相感光构件,处理盒和电子照相设备,其不仅充分确保机械强度,而且还可以极大地改善电荷传输性能,并且可以很好地满足电性能。 提供电子照相感光构件,其最外表面层至少包含由以下通式(1-1)或(1-2)表示的具有链可聚合官能团的电荷输送化合物; 电荷输送化合物已经聚合或交联并固化。 还提供了具有这种感光构件的处理盒和电子照相设备。

    Condensed purine derivatives
    8.
    发明授权
    Condensed purine derivatives 失效
    凝血嘌呤衍生物

    公开(公告)号:US06306847B1

    公开(公告)日:2001-10-23

    申请号:US09090936

    申请日:1998-06-05

    CPC classification number: C07D487/14

    Abstract: The present invention provides condensed purine derivatives or pharmacologically acceptable salts thereof exhibiting adenosine A3 acceptor antagonising activity, and having an antiasthmatic action, a bronchodilator action, an antiantiitching action, etc., and represented by the following formula (I): (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group; R2 represents hydrogen, lower alkyl, alicyclic alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, or a substituted or unsubstituted aromatic heterocyclic group; R3 represents hydrogen, lower alkyl, or substituted or unsubstituted aralkyl; X1 and X2 are the same or different and each represents hydrogen, lower alkyl, substituted or unsubstituted aralkyl, or substituted or unsubstituted aryl; and n represents an integer of 0 to 3).

    Abstract translation: 本发明提供具有腺苷A3受体拮抗活性的缩合嘌呤衍生物或其药理学上可接受的盐,并具有抗哮喘作用,支气管扩张剂作用,抗脱除作用等,并由下式(I)表示:(其中R1表示 取代或未取代的芳基或取代或未取代的芳族杂环基; R 2表示氢,低级烷基,脂环族烷基,取代或未取代的芳烷基,取代或未取代的芳基或取代或未取代的芳族杂环基; R 3表示氢,低级烷基或 取代或未取代的芳烷基; X 1和X 2相同或不同,各自表示氢,低级烷基,取代或未取代的芳烷基或取代或未取代的芳基; n表示0〜3的整数。

    Calcitonin derivatives
    9.
    发明授权
    Calcitonin derivatives 失效
    降钙素衍生物

    公开(公告)号:US5977298A

    公开(公告)日:1999-11-02

    申请号:US934741

    申请日:1997-09-22

    CPC classification number: C07K14/585

    Abstract: The present invention relates to compounds represented by formula (I): ##STR1## wherein Z represents Gly or Cys; X represents an (.alpha.-amino acid residue; Y represents a natural calcitonin moiety, a partial natural calcitonin peptide moiety, or a natural calcitonin-like peptide moiety; m represents an integer of 5-8, .alpha.-amino acid residues represented by X being the same or different; and n represents an integer of 0-3; provided that when m is 5, the sequence of 4 C-terminal residues of --(X).sub.m -- is different from the sequence of the third to sixth amino acids of natural calcitonin, and pharmaceutically acceptable salts thereof.

    Abstract translation: 本发明涉及由式(I)表示的化合物:其中Z表示Gly或Cys; X表示(α-氨基酸残基; Y表示天然降钙素部分,部分天然降钙素肽部分或天然降钙素样肽部分; m表示5-8的整数,X表示的α-氨基酸残基 相同或不同; n表示0-3的整数;条件是当m为5时, - (X)m-的4 C-末端残基的序列与第三至第六氨基酸的序列不同 的天然降钙素及其药学上可接受的盐。

    Xanthine derivatives
    10.
    发明授权
    Xanthine derivatives 失效
    黄嘌呤衍生物

    公开(公告)号:US5756735A

    公开(公告)日:1998-05-26

    申请号:US483159

    申请日:1995-06-07

    CPC classification number: C07D473/06

    Abstract: The present invention relates to novel xanthine derivatives of the formula (I) which are selectively antagonistic to an adenosine A.sub.2 receptor, and pharmaceutically acceptable salts thereof. Formula (I): ##STR1## In the formula, R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a propyl group, a butyl group or an allyl group; R.sup.3 represents a hydrogen atom or a lower alkyl group; Y.sup.1 and Y.sup.2 are the same or different and each represents a hydrogen atom or a methyl group; and Z represents a substituted or unsubstituted phenyl group, a pyridyl group, an imidazolyl group, a furyl group or a thienyl group.

    Abstract translation: 本发明涉及对腺苷A2受体选择性拮抗的式(I)的新颖黄嘌呤衍生物及其药学上可接受的盐。 式(I):(I)式中,R 1和R 2相同或不同,表示氢原子,丙基,丁基或烯丙基; R3表示氢原子或低级烷基; Y1和Y2相同或不同,各自表示氢原子或甲基; Z表示取代或未取代的苯基,吡啶基,咪唑基,呋喃基或噻吩基。

Patent Agency Ranking